Abstract
A comparative study of the supercritical fluid micronization of risperidone pharmaceutical substance with an initial particle size of 50 to 100 μm by the RESS and SAS methods aimed at increasing the bioavailability of risperidone as a drug was performed. Both methods makes it possible to prepare risperidone particle of various forms, 5–20 μm in size. However, the SAS method is preferable, because in contrast to RESS, it does not cause contamination of risperidone with organic solvents used in both processes or any other impurities and also makes it possible to vary the shape and size of particles. It is shown that, during SAS micronization, the polymorphic form of risperidone changes from triclinic to monoclinic.
Similar content being viewed by others
References
T. L. Rogers, K. A. Overhoff, P. Shah, P. Santiago, M. J. Yacaman, K. P. Johnston, and R. O. Williams III, Eur. J. Pharm. Biopharm. 55, 161 (2003).
P. Pathak, M. J. Mezjani, T. Desai, and Y.-P. Sun, J. Am. Chem. Soc. 126, 10842 (2004).
K. Giry, J. M. Pean, L. Giraud, S. Marsas, H. Rolland, and P. Wuthrich, Int. J. Pharm. 321, 162 (2006).
Y. H. Kim, C. Sioutas, P. Fine, and K. S. Shing, Powder Technol. 182, 354 (2008).
D. Hermsdorf, S. Jauer, and R. Signorell, Mol. Phys. 105, 951 (2007).
M. Bahrami and S. Ranjbarian, J. Supercrit. Fluids 40, 263 (2007).
E. Reverchon, G. Della Porta, and A. Spada, J. Pharm. Pharmacol. 55, 1465 (2003).
E. Reverchon, G. Della Porta, A. Spada, and A. Antonacci, J. Pharm. Pharmacol. 56, 1379 (2004).
T. K. Bastaman, R. Budiman, A. Kumawardhani, A. N. Irmansyah, and R. Salan, Eur. Neuropshychopharmacol. 6(Suppl. 3, Orals), 149 (1996).
D. Kayrak, U. Akman, and S. U. Hortace, J. Supercrit. Fluids 26, 17 (2003).
I. Karabas, M. G. Orkoula, and C. G. Kontoyannis, Talanta 71, 1382 (2007).
M. Leigh, T. Reimann, J. Grunkemeyer, B. Schneider, H. Schwebel, and P. van Hoogevest, “A Polymorphism Screen of Risperidone: A comparison of XRPD and Raman Spectroscopy,” AAPS J. 9(S2) (2007).
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.N. Bagratashvili, A.M. Egorov, L.I. Krotova, A.V. Mironov, V.Ya. Panchenko, O.O. Parenago, V.K. Popov, I.A. Revelsky, P.S. Timashev, S.I. Tsypina, 2011, published in Sverkhkriticheskie Flyuidy: Teoriya i Praktika, 2011, Vol. 6, No. 4, pp. 88–102.
Rights and permissions
About this article
Cite this article
Bagratashvili, V.N., Egorov, A.M., Krotova, L.I. et al. Supercritical fluid micronization of risperidone pharmaceutical substance. Russ. J. Phys. Chem. B 6, 804–812 (2012). https://doi.org/10.1134/S1990793112070019
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990793112070019